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Abstract 
In healthcare, a tremendous amount of clinical 
and laboratory tests, imaging, prescription and 
medication data are being collected. Big data 
analytics on these data aim at early detection of 
disease which will help in developing preventive 
measures and in improving patient care. Parkinson 
disease is the second-most common 
neurodegenerative disorder in the United States. To 
find a cure for Parkinson's disease biological, 
clinical and behavioral data of different cohorts are 
collected, managed and propagated through 
Parkinson’s Progression Markers Initiative (PPMI). 
Applying big data technology to this data will lead to 
the identification of the potential biomarkers of 
Parkinson’s disease. Data collected in human 
clinical studies is imbalanced, heterogeneous, 
incongruent and sparse. This study focuses on the 
ways to overcome the challenges offered by PPMI 
data which is wide and gappy. This work leverages 
the initial discoveries made through descriptive 
studies of various attributes. The exploration of data 
led to identifying the significant attributes. We are 
further working to build a software suite that enables 
end to end analysis of Parkinson’s data (from 
cleaning and curating data, to imputation, to 
dimensionality reduction, to multivariate correlation 
and finally to identify potential biomarkers). 
 
 
1.Introduction 
 
Parkinson’s Disease (PD) is a neurodegenerative 
disorder and millions of people suffer with it all over 
the world. The incidence of PD increases with the 
age growth, about 6.3 million people live with this 
disease. Especially, in developed country, the number 
of patients with PD has increased signiﬁcantly in 
recent years. However, there are no methods which 
can measure the PD progression efﬁciently and 
accurately in its early stages [1]. The last known drug 
for Parkinson’s disease was found in 1967. 
Common symptoms in PD are muscular rigidity 
(inflexibility of muscles), shivering (vibration in 
upper and lower limbs or jaws), speech problem, 
expressionless face, Bradykinesia (slow movements), 
lethargy, postural instability (depression and 
emotional changes), involuntary movements, 
dementia (loss of memory), thinking inability and 
sleeping disorders. Various stages of Parkinson’s 
disease are,   
 Primary - Due to unknown reasons  
  Secondary - Dopamine deficiency  
  Hereditary- Genetic origin  
 Multiple system atrophy - Degeneration of 
parts other than midbrain  
For traditional PD assessment, Movement 
Disorder Society-sponsored Uniﬁed Parkinson 
Disease Rating Scale (MDS-UPDRS) is wildly used. 
To better understand PD progression and to identify 
potential biomarkers PPMI (Parkinson’s Progression 
Markers Initiative) was set up. Clinical sites in the 
United States, Europe, Israel and Australia contribute 
to the comprehensive study. PPMI is funded by the 
Micheal J. Fox Foundation. PPMI collects clinical, 
biological and imaging data from multiple sites and 
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 disseminates it. This data is used to diagnose, track 
and predict PD and its progression.     
Parkinson’s data possess all the characteristics of 
big data, which are characterized by volume, variety, 
velocity, veracity, and value. From the context of 
Parkinson’s data, these five Vs are further detailed as 
below. 
 Volume – With more and more attributes 
being collected for the Parkinson’s research 
and with the increase in participation of 
different cohorts through various initiatives, 
the volume of the data is growing. 
  Variety –Parkinson’s disease contains 
structured, text, images, audio and semi-
structured data collected from the various 
smart fitness tracking devices  
 Velocity-Velocity is depicted by the speed 
in which data is created, stored and 
processed. Nowadays real-time processing 
systems aid in real-time decision making.  
 Veracity- Veracity deals with integrity of 
data. Data quality issues and reliability of 
the information are the key elements in 
veracity. Parkinson’s data is heterogeneous, 
multi-source, incomplete, incongruent and 
sparse. 
 Value- Extracting value from the data is the 
goal of big data analytics. 
The goal of working with the Parkinson’s data 
from the public databases is to find potential 
biomarkers thereby finding a cure for the disease. 
Cleaning and curating data, however, to discover 
patterns from it is very challenging [2]. 
The main contribution of this study is to identify 
significant attributes that lead to PD. We first 
grouped 1358 unique attributes to six major 
categories. The data is then cleaned and curated. 
Redundancy in attributes was removed. Out of 2600 
attributes, only 1358 were unique attributes. 
Descriptive studies of all these attributes were done. 
We wish to answer several questions in our research 
 How can we discover the potential 
biomarkers of Parkinson’s disease by using 
big data methodologies? 
 Is it possible to use various machine 
learning algorithms to help in early detection 
of Parkinson’s disease? 
 What are the data that needs to be analyzed 
to discover the biomarkers of Parkinson’s 
disease? 
 How can we develop an interactive 
visualization that helps physicians 
understand the relations between various 
attributes that are a potential cause of 
Parkinson’s disease? 
 Is it feasible to scale the visualization for 
many user inputs? Does it yield the same 
result as the initial visualization with the 
training set? 
In this study, we first tried understanding the 
attributes and created a metadata of the attributes. We 
did descriptive studies and computed the average of 
PD and HC for all the attributes to identify significant 
or important attributes. Curating the incomplete, 
heterogeneous data has proven to be the biggest 
challenge. 
 
2. Related Work 
 
In recent years, big data technologies are widely 
used in healthcare for earlier diagnosis of diseases 
and to provide better patient care. Dinov et al [3] 
illustrated bigdata’s challenges and the role of big 
data technology in the biomedical field. They explore 
how the volume, variety, and velocity of biomedical 
data have tremendously increased. The challenges 
posed by biomedical data analysis is overcome by the 
pipeline environment. The pipeline is a crowd-based 
distributed solution for consistent management of 
these heterogeneous resources. The pipeline allows 
multiple (local) clients and (remote) servers to 
connect, exchange protocols, control the execution, 
monitor the states of different tools or hardware, and 
share complete protocols as portable XML 
workflows.  As stated in their paper, Laboratory of 
Neuro Imaging (LONI) is one such pipeline 
environment for Parkinson’s big data research. LONI 
seeks to improve understanding of the brain in health 
and disease.  
Big Data analytics is applied on data collected by 
LONI from different sources. Machine learning 
techniques help to predict the PD at an earlier stage. 
Chen et al. [4] present an effective and efficient 
diagnosis system using fuzzy k-nearest neighbor 
(FKNN) for Parkinson’s disease (PD) diagnosis. The 
proposed FKNN-based system is compared with the 
support vector machines (SVM) based approaches. 
To further improve the diagnosis accuracy for 
detection of PD, principle component analysis was 
employed. The effectiveness of the proposed system 
has been rigorously estimated on a PD dataset in 
terms of classification accuracy, sensitivity, 
specificity and the area under the receiver operating 
characteristic (ROC) curve. Experimental results 
have demonstrated that the FKNN-based system 
greatly outperforms SVM-based approaches and 
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 other methods in the literature. Gracy et al. [5] have 
discussed the four types of classifiers namely, Naive 
Bayes, Random tree, J48 and decision tree. Shivering 
hands, legs, arms or jaws and emotional changes are 
the factors considered in the study. 
In the era of big data, the data quality is a big 
challenge when applying machine learning 
techniques and derive value from it. Ramentol et.al. 
[6] have stated that imbalanced data is a common 
problem in classification. Their paper proposes a new 
hybrid method for preprocessing imbalanced data-
sets through the construction of new samples, using 
the Synthetic Minority Oversampling Technique 
together with the application of an editing technique 
based on the Rough Set Theory and the lower 
approximation of a subset. The proposed method has 
been validated by an experimental study showing 
good results using C4.5 as the learning algorithm.  
Cho et al. [7] proposed a system for combining 
principal component analysis (PCA) with linear 
discriminant analysis (LDA). They proposed a gait 
analysis system which can detect the gait pattern of 
Parkinson’s disease using computer vision. Dinov et 
al.  [8] introduces methods for rebalancing 
imbalanced cohorts and utilizes a wide spectrum of 
classification methods to generate consistent and 
powerful phenotypic predictions. It generates 
reproducible machine learning based classification 
that enables the reporting of model parameters and 
diagnostic forecasting based on new data.  
Data collected in clinical studies is complex. Data 
visualization is paramount to enhance the 
understanding of data. Maciejewski et al. [9] have 
provided visual analytics systems to users to explore 
trends in their data. Linked views and interactive 
displays provide insight into correlations among 
people, events, and places in space and time. 
Furthermore, this study helps facilitate forecasting, as 
it has created a predictive visual analytics toolkit that 
provides researchers with linked spatiotemporal and 
statistical analytic views. Though there are several 
machine learning algorithms that have been 
implemented on different datasets on Parkinson there 
is no software developed to visually explore the 
correlations among various attributes and PD 
progression. Our study aims to visualize the risk 
factors and their relationship to PD.  
 
3.Research Goals 
 
Data collected from PPMI study consists of 
clinical, biological and imaging data of various 
patients. There are 2600 attributes and the number is 
constantly increasing as it is an ongoing study. This 
paper addresses the general challenges of data 
curation, munging, aggregation, and preliminary 
descriptive analyses of the PPMI data. This paper 
provides the results of the preliminary analyses. 
Cleaning and curating the data is the biggest 
challenge. Each file was taken individually, 
redundant and administrative data that was not 
required for the study was removed.  Aggregating 
these wide attributes together creates a huge sparse 
matrix. Finding the correlation between various 
attributes and visualizing them is the goal of this 
paper. Merits – This framework with a simple 
interactive visualization will abstract people from 
sophisticated mathematics to provide a simplified and 
understandable version of the disease to the life style 
of a common man.  
After doing the initial analysis we have 
formulated two long term objectives for our study. 
Long term objective 1 focuses on tools for curating 
and imputing missing data using a set of novel 
algorithms.    
Long term objective 2 consists of tools for 
reducing the dimensionality of the post-imputation 
data. End-users may effortlessly deploy several 
dimensionality reduction strategies, visually explore, 
and pick the most insightful approach. 
 
4. Data 
 
The PPMI study dataset is disseminated by PPMI 
Bioinformatics Core at the University of Southern 
California. This database includes clinical, biological 
and imaging data collected at various participating 
sites. PPMI also collects biologic specimens 
including urine, plasma, serum, cerebrospinal fluid, 
DNA, and RNA. The complete PPMI data set 
includes Biospecimen (ex: Lab reports, Blood 
sample), Imaging, Medical History, Subject 
Characteristics (ex: Demographics), Motor 
Assessment, and Non-Motor Assessment. 
 
Table 1. Details of Files in PPMI 
 
No of Files (CSV/Tables) 92 
No of Files containing Administrative 
Data 12 
No of Files containing Clinical, 
Questionnaire data 80 
 
 
Table 2. Details of Various Attributes in PPMI 
 
Total Number of Attributes 2600 
Total Number of Unique Attributes 1358 
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 Numerical Attributes 779 
Categorical Attributes 1316 
Time 47 
Date 458 
 
The dataset obtained from PPMI for our study 
consists of 1479 patients. PD are patients with 
Parkinson’s disease and 418 PD patients were 
considered in our study. Healthy control (HC) was 
172 in number. We considered 418 PD, 172 HC and 
62 Prodromal patients (In medicine, a prodrome is an 
early sign or symptom or set of signs and symptoms, 
which often indicate the onset of a disease before 
more diagnostically specific signs and symptoms 
develop). These totals up to 652 out of 1479 patients. 
The remaining 827 are genetic cohorts and genetic 
registry patients will be considered in the future 
research. Genetic Cohort PD, Genetic Cohort 
Unaffected, Genetic Registry PD, and Genetic 
Registry Unaffected are the other Cohorts in the 
dataset, but these cohorts were not included in the 
current study.  
 
 
Table 3. Details of Patient Status 
 
HC - Healthy Control 172 
PD - Parkinson's Disease 418 
 
4.1. Data Categorization 
 
Data from various files are categorized into six 
major categories such as  
a) Biospecimen (ex: Lab reports, Blood sample), 
b) Imaging (ex: DaTscan imaging, Magnetic 
Resonance Imaging) 
c) Medical History (ex: General medical history, 
General neurological exam, General physical 
exam, Pregnancy forms, Neurological exam 
cranial nerves) 
d) Subject Characteristics (ex: demographics, 
PPMI took place at clinical sites in the United 
States, Europe, Israel, and Australia),  
e) Motor Assessment (ex: assessment of tremor 
with bradykinesia, assessment of tremors in 
tongue, jaw, lower lip, hand or in the leg/foot. 
Movement Disorder Society (MDS) offers 
Unified Parkinson’s Disease Rating Scale 
(UPDRS) which guides in the motor 
assessment), and  
f) Non-Motor Assessment (ex: assessment of 
verbal learning, semantic fluency and 
sleepiness scale are some of the non-motor 
assessment tests). 
Figure 1 is visual representation of the file and its 
category. This categorization helps us understand the 
attributes better on a high level. 
 
Table 4. Details of Various Data Categories 
after Data was Analyzed and Cleaned 
 
Category Number of Files 
Biospecimen 11 
Imaging 9 
Medical History 14 
Motor Assessment 11 
Non-Motor Assessment 16 
Subject Characteristics 5 
 
 
 
 
 
Figure 1. Data Categories 
 
 
5.  Analyses and Findings 
The individual data files were cleaned and 
redundant data were removed. Out of initial 92 
files(as mentioned in table 1) , only 66 files (as 
mentioned in table 4) contained the features 
associated with Parkinson’s disease.  The 
administrative data about the enrollment status of 
different cohorts were excluded. The final list after 
removing the redundant and administrative attributes 
had 978 attributes. A descriptive study of all 
attributes was done. Mean, median, minimum, 
maximum, mode and standard deviation of all the 
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 978 attributes were calculated. After the preliminary 
data exploration, we studied the correlation of 
different attributes with the patient status.  
Data was mapped to the same standardized 
names. (ex: Some files had attributes called subject id 
and some had attributes called Patient Number). 
Once the data was standardized. All the data was 
loaded into PostgreSQL database. The data model of 
the database has the six main categories such as 
biospecimen, imaging, motor assessment, non-motor 
assessment, medical history and subject 
characteristics.  
Metadata file containing the information about 
the data was created.  
 
 
Figure 2. A High-Level Overview of the Data 
Model 
 
     All the data from PPMI after cleaning was loaded 
into a PostgreSQL database. Figure 2 gives a high 
level data model of the database. This indicates how 
the tables were created and data was loaded. 
 
5.1. Significant Attributes 
  
Once all the attributes are aggregated, the average 
value for Parkinson’s disease PD and healthy control 
HC cohort was calculated. The difference in the value 
was normalized. Figure 3 illustrates how the average 
value of PD and HC appear after normalization. The 
values are between 0 and 1 and easy to compare. The 
difference in value was visualized in Tableau which 
was connected to the database as illustrated in figure 
4. The attributes with a significant difference in value 
were identified. In a high dimensional dataset 
discovering the important features is crucial. The 
study results demonstrated the attributes in 
MDS_UPDRS_Part_III had the significant attributes. 
 
 
 
Figure 3. Normalized Data 
 
 
 
Figure 4. Attributes with Significant 
Difference between PD and HC Values. 
 
We also, explored the correlations among the 
attributes using circos visualizations. See figure 5. 
Circos visualization is an interactive tool in that we 
can isolate the relationship between one attribute and 
all other attributes, displaying the strength of the 
correlation as a measure of the width of the flare. An 
interactive version will be provided later. 
 
 
 
Figure 5. Circos Visualization with 
Significant Attributes. 
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Figure 6. Circos Visualization Displaying 
Correlation between Attributes. 
 
Figure 6. illustrates how UPDRS (Unified 
Parkinson’s Disease Rating Scale) is highly 
correlated with bradykinesia, postural instability, 
hallucination and speech. Furthermore, the graph is 
interactive as we can hover-over the visualization to 
find the correlations of any other attributes with 
others.  
 
6. Challenges in Dataset 
 
The dataset from PPMI is wide with 2600 
attributes. The complexity is furthermore increased as 
it is a time series data. Curating and stacking the data 
is a big challenge. The data is incomplete, 
imbalanced and incompatible. When data is 
aggregated together there are lots of missing value. 
Only 30% of data is available. Imputing the 
missing value is of paramount importance for 
implementing various machine learning algorithms 
on the data to identify the potential biomarkers. 
 To overcome the challenges posed by human 
clinical datasets we are researching on a set of novel 
algorithms. (a) Singular Value Decomposition type 
imputation, (b) gappy Tensor decomposition, and (c) 
standard knn based imputation. The latter approach, 
prevalent in biomedical research, will serve as a 
benchmark. The two former methods (especially the 
Tensor decomposition) have shown phenomenal 
ability to impute complex datasets in engineering 
problems and will translate into novel approaches for 
biomedical data. 
 
7. Conclusion 
 
Currently, data from clinical and behavioral 
studies of PD are growing rapidly and with little 
knowledge or coordination of attributes collected. 
Understanding the importance of each attribute 
collection to PD detection and treatment is important 
and our work helps highlight the challenges in data 
quality and tools to improve the same. Future work 
can be extended by allowing researchers to add 
additional attributes and determine their role in PD. 
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